Key Metrics
CiteScore 

6.8
Impact Factor 

< 5
SJR 

Q2Pharmacology

SNIP 

1.53
Recommended pre-submission checks
Powered by 

Topics Covered on Saudi Pharmaceutical Journal
Saudi Pharmaceutical Journal Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Bi-monthly |
| Article Processing Charges | USD 1450 |
| Publication Time | 12 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | King Saud University |
| Frequency | Bi-monthly |
| Publication Start Year | 1993 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Saudi Pharmaceutical Journal ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Saudi Pharmaceutical Journal
Formononetin attenuates glucocorticoid-induced osteoporosis via multiple osteoimmunological pathways: evidence from zebrafish and network pharmacology
- 1 Aug 2026
- Saudi Pharmaceutical Journal : SPJ
Melittin attenuates imiquimod-induced psoriatic dermatitis in mice: a role for autophagy activation via PI3K/Akt/mTOR pathway suppression
- 1 Aug 2026
- Saudi Pharmaceutical Journal : SPJ
A real-world, bottom-up cost of illness analysis of type 2 diabetes mellitus from a tertiary hospital in Saudi Arabia
- 1 Aug 2026
- Saudi Pharmaceutical Journal : SPJ
Therapeutic potential of phytochemical compounds in cardiovascular disease: a comprehensive review
- 1 Aug 2026
- Saudi Pharmaceutical Journal : SPJ
Co-amorphization for solubility and dissolution rate improvement: the case of low-crystallization-tendency drugs
- 30 Jul 2026
- Saudi Pharmaceutical Journal : SPJ
Adherence to evidence-based guidelines for the management of candiduria in a tertiary care center in Riyadh: A retrospective cross-sectional study
- 28 Jul 2026
- Saudi Pharmaceutical Journal : SPJ
Formononetin attenuates glucocorticoid-induced osteoporosis via multiple osteoimmunological pathways: evidence from zebrafish and network pharmacology
- 1 Aug 2026
- Saudi Pharmaceutical Journal : SPJ
Melittin attenuates imiquimod-induced psoriatic dermatitis in mice: a role for autophagy activation via PI3K/Akt/mTOR pathway suppression
- 1 Aug 2026
- Saudi Pharmaceutical Journal : SPJ
A real-world, bottom-up cost of illness analysis of type 2 diabetes mellitus from a tertiary hospital in Saudi Arabia
- 1 Aug 2026
- Saudi Pharmaceutical Journal : SPJ
Therapeutic potential of phytochemical compounds in cardiovascular disease: a comprehensive review
- 1 Aug 2026
- Saudi Pharmaceutical Journal : SPJ
Co-amorphization for solubility and dissolution rate improvement: the case of low-crystallization-tendency drugs
- 30 Jul 2026
- Saudi Pharmaceutical Journal : SPJ
Adherence to evidence-based guidelines for the management of candiduria in a tertiary care center in Riyadh: A retrospective cross-sectional study
- 28 Jul 2026
- Saudi Pharmaceutical Journal : SPJ